Tags: Cancer | drug | extends | lives | liver | cancer | patients

Drug Extends Lives of Liver Cancer Patients

Drug Extends Lives of Liver Cancer Patients
(Copyright AP)

Thursday, 05 May 2016 09:06 AM

Bayer AG said on Thursday its Regorafenib cancer treatment drug helped extend the lives of liver cancer sufferers according to the results of a Phase III clinical trial.

Bayer now plans to file for regulatory approval of the oncology compound, which is also know as Stivarga, it said.

The German company said it plans to submit the data from its study as the basis for marketing authorization of Regorafenib in the treatment of inoperable liver cancer in 2016.

© 2021 Thomson/Reuters. All rights reserved.


   
1Like our page
2Share
Health-News
Bayer AG said on Thursday its Regorafenib cancer treatment drug helped extend the lives of liver cancer sufferers according to the results of a Phase III clinical trial. Bayer now plans to file for regulatory approval of the oncology compound, which is also know as...
drug, extends, lives, liver, cancer, patients, Regorafenib
78
2016-06-05
Thursday, 05 May 2016 09:06 AM
Newsmax Media, Inc.
 
Newsmax TV Live

The information presented on this website is not intended as specific medical advice and is not a substitute for professional medical treatment or diagnosis. Read Newsmax Terms and Conditions of Service.

Newsmax, Moneynews, Newsmax Health, and Independent. American. are registered trademarks of Newsmax Media, Inc. Newsmax TV, and Newsmax World are trademarks of Newsmax Media, Inc.

NEWSMAX.COM
© Newsmax Media, Inc.
All Rights Reserved